MedTrace Logo

FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study

NCT04464772 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2020-11-18

No results posted yet for this study

Summary

The purpose of this study is to characterize the Freestyle Libre Glucose Monitoring System in pediatric and adult subjects with respect to YSI reference venous plasma sample measurements.

Conditions

Interventions

DEVICE

FreeStyle Libre 3

FreeStyle Libre 3 Continuous Glucose Monitoring System

Sponsors & Collaborators

  • Abbott Diabetes Care

    lead INDUSTRY

Principal Investigators

  • Shridhara A Karinka, PhD · Abbott Diabetes Care

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-10
Primary Completion
2020-09-14
Completion
2020-09-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04464772 on ClinicalTrials.gov